Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06848101 · ClinicalTrials.gov registry record · NA

Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)

A NA study of Vision and Eye Health, sponsored by University of Illinois at Urbana-Champaign.

Active
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT06848101: Active NA study of Vision and Eye Health, sponsored by University of Illinois at Urbana-Champaign.

NCT06848101 is a NA study of Vision and Eye Health that is active but no longer recruiting, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 40 participants, below the 2,086-participant average among 5 other Vision trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06848101, a NA study of Vision and Eye Health, is active but no longer recruiting, sponsored by University of Illinois at Urbana-Champaign.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary study outcomes are to investigate the effects of 4-month daily carotenoid complex supplementation on carotenoid status in the macula and skin and visual fatigue among adults 20-45 years of age. Secondary outcomes will examine the supplementation effects on cognitive function.

Primary Outcome

Macular carotenoids assessed using heterochromatic flicker photometry

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Carotenoid Group
  • DIETARY_SUPPLEMENT Control (placebo) group

Study Locations (1)

Illinois

  • University of illinois - Urbana

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-03-15
Est. Completion 2025-03-14
Phase NA

What the registry record for NCT06848101 still lists

NCT06848101 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 2,086-participant average among 5 other Vision trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Vision appearing as the primary indexed condition, and to 2 interventions - of which Carotenoid Group is the first listed.

NCT06848101 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06848101 about?

NCT06848101 is a clinical study titled "Eye and Carotenoid Augmentation Research and Evaluation (EyeCARE)". The primary study outcomes are to investigate the effects of 4-month daily carotenoid complex supplementation on carotenoid status in the macula and skin and visual fatigue among adults 20-45 years of age. Secondary outcomes will examine the supplementation effects on cognitive function.

What is the current status of trial NCT06848101?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2024-03-15. Estimated completion is 2025-03-14.

What conditions does trial NCT06848101 study?

This clinical trial studies the following conditions: Vision, Eye Health.

What interventions are being tested in trial NCT06848101?

The interventions under investigation include: Carotenoid Group (DIETARY_SUPPLEMENT), Control (placebo) group (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06848101?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06848101 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vision

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06848101, the US trial registry maintained by the National Library of Medicine. NCT06848101 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.